CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
@article{PCM5895,
author = {Emily F. Collier and Sarah B. Goldberg},
title = {CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC},
journal = {Precision Cancer Medicine},
volume = {3},
number = {0},
year = {2020},
keywords = {},
abstract = {},
issn = {2617-2216}, url = {https://pcm.amegroups.org/article/view/5895}
}